EMTRICITABINE\TENOFOVIR for Hepatitis c: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where EMTRICITABINE\TENOFOVIR was used for Hepatitis c.
Most Reported Side Effects for EMTRICITABINE\TENOFOVIR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 404 | 13.6% | 57 | 35 |
| Death | 205 | 6.9% | 203 | 10 |
| Maternal exposure during pregnancy | 196 | 6.6% | 7 | 17 |
| Drug ineffective | 175 | 5.9% | 1 | 5 |
| Hiv infection | 172 | 5.8% | 3 | 6 |
| Exposure during pregnancy | 164 | 5.5% | 9 | 21 |
| Abortion spontaneous | 141 | 4.8% | 12 | 13 |
| Virologic failure | 129 | 4.4% | 6 | 3 |
| Neurodevelopmental disorder | 80 | 2.7% | 0 | 0 |
| Nausea | 67 | 2.3% | 2 | 18 |
| No adverse event | 62 | 2.1% | 0 | 2 |
| Immune reconstitution inflammatory syndrome | 60 | 2.0% | 3 | 32 |
| Treatment noncompliance | 60 | 2.0% | 1 | 11 |
| Drug resistance | 55 | 1.9% | 0 | 5 |
| Premature baby | 55 | 1.9% | 9 | 13 |
Other Indications for EMTRICITABINE\TENOFOVIR
Hiv infection (1,459)
Prophylaxis against hiv infection (635)
Product used for unknown indication (470)
Antiretroviral therapy (131)
Maternal exposure timing unspecified (35)
Acquired immunodeficiency syndrome (21)
Prophylaxis (18)
Foetal exposure during pregnancy (17)
Hepatitis b (12)
Supplementation therapy (8)
Other Drugs Used for Hepatitis c
RIBAVIRIN (20,657)
PEGINTERFERON ALFA-2A (10,970)
LEDIPASVIR\SOFOSBUVIR (8,924)
DASABUVIR\OMBITASVIR\PARITAPREVIR\RITONAVIR (8,264)
SOFOSBUVIR (7,691)
SOFOSBUVIR\VELPATASVIR (4,956)
GLECAPREVIR\PIBRENTASVIR (4,016)
OMBITASVIR\PARITAPREVIR\RITONAVIR (2,906)
TELAPREVIR (2,604)
DASABUVIR (2,603)